Educational Session. Chair: Shotaro Maeda Tama-Nagayama Hospital, Nippon Medical School, Japan. Mechanisms of asbestos-induced carcinogenesis
|
|
- Marcia Haynes
- 8 years ago
- Views:
Transcription
1 Tuesday, Aug. 31 Room A Time: 8:00-8:10 Opening Remarks Time: 8:10-8:35 The mesothelial cell ES01 Time: 8:35-9:00 Educational Session Chair: Shotaro Maeda Tama-Nagayama Hospital, Nippon Medical School, Japan The mesothelial cell Steven Mutsaers Lung Institute of Western Australia and Centre for Asthma, Allergy and Respiratory Research, Department of Medicine, University of Western Australia, Australia Mechanisms of asbestos-induced carcinogenesis ES02 Time: 9:00-9:25 Chair: Naohiko Inase Tokyo Medical and Dental University, Japan Mechanisms of asbestos-induced carcinogenesis Marie-Claude Jaurand INSERM, UMR U-674, IUH Université Paris Descartes, France Apoptosis and ES03 Time: 9:25-9:50 Chair: Hirotoshi Akita Hokkaido University Graduate School of Medicine, Japan Apoptosis and Courtney Broaddus University of California, San Francisco, Chief, Division of Pulmonary and Critical Care Medicine San Francisco General Hospital, USA New pathways for molecular targeted therapies ES04 Takashi Nakano, Conference Chair IMIG 2010 Hyogo College of Medicine, Japan Chair: Kazuhisa Takahashi Juntendo University School of Medicine, Japan New pathways for molecular targeted therapies Luciano Mutti Department of Medicine, Local Health Unit 11, Vercelli, Italy 21
2 Time: 9:50-10:15 Clinically relevant chromosomal and molecular biomarkers in asbestos-related tumors ES05 Time: 10:35-11:00 Chair: Yoshitaka Sekido Aichi Cancer Center, Hospital and Research Institute, Japan Clinically relevant chromosomal and molecular biomarkers in asbestos-related tumors Sakari Knuutila Department of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland Clinical aspects of malignant pleural ES06 Time: 11:00-11:25 Chair: Yoshirou Mochiduki National Hospital Organization Himeji Medical Center, Japan Clinical aspects of malignant pleural Hugo Schouwink Department of Pulmonary Diseases Medisch Spectrum Twente, Enschede, The Netherlands Peritoneal -Clinical and translational research in pharmacology of cancer chemotherapy- ES07 Time: 11:25-11:50 Chair: Eiji Shimizu Tottori University Faculty of Medicine, Japan Peritoneal Clinical and translational research in pharmacology of cancer chemotherapy Paul Sugarbaker Washington Cancer Institute, Washington, DC, USA Malignant Mesothelioma new diagnostic tools ES08 Time: 13:00-13:25 Chair: Hiroshi Niwa Seirei Mikatahara General Hospital, Japan Malignant new diagnostic tools Bruce Robinson National Centre for Asbestos Related Diseases, University of Western Australia, Australia Systemic therapy for : First and second-line treatment ES09 Chair: Mikio Oka Kawasaki Medical School, Japan Systemic therapy for : First and second-line treatment Hedy Kindler Section of Hematology/Oncology, University of Chicago, USA 22
3 Time: 13:25-13:50 Palliative benefit of chemotherapy for ES10 Time: 13:50-14:15 Chair: Yukito Ichinose National Kyushu Cancer Center, Japan Palliative benefit of chemotherapy for Jeremy Steele Department of Medical Oncology, St Bartholomew s Hospital, UK Immunotherapy for ES11 Time: 14:15-14:40 Chair: Yasuhiko Nishioka The University of Tokushima Graduate School, Japan Immunotherapy for Steven Albelda Thoracic Oncology Gene Therapy Program, University of Pennsylvania Medical Center, USA Gene therapy for ES12 Time: 15:00-15:25 Chair: Yoshinori Hasegawa Nagoya University Graduate School of Medicine, Japan Gene therapy for Daniel Sterman Thoracic Oncology Gene Therapy Program, University of Pennsylvania Medical Center, USA TNM staging of malignant pleural ES13 Time: 15:25-15:50 Chair: Shinichiro Miyoshi Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan TNM staging of malignant pleural Valerie Rusch Thoracic Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, USA Role of radical surgery within a multimodality concept ES14 Chair: Hiroshi Date Graduate School of Medicine and Faculty of Medicine, Kyoto University, Japan Role of radical surgery within a multimodality concept Walter Weder Division of Thoracic Surgery, University Hospital Zürich, Switzerland 23
4 Time: 15:50-16:15 Overview of the surgical debate for pleural ES15 Time: 16:45-17:10 Chair: Masahiro Tsuboi Kanagawa Cancer Center, Japan Overview of the surgical debate for pleural Harvey Pass Division of Thoracic Surgery and Thoracic Oncology, Department of Cardiothoracic Surgery, NYU Langone Medical Center and Cancer Center, USA Multimodality treatment of MPM ES16 Time: 17:10-17:35 Chair: Koichi Kaneko Saitama Medical University International Medical Center, Japan Multimodality treatment of MPM Paul Baas Department of Thoracic Oncology, The Netherlands Cancer Institute, The Netherlands European guidelines for the treatment of malignant pleural ES17 Time: 17:35-18:00 Chair: Meinoshin Okumura Osaka University Graduate School of Medicine, Japan European guidelines for the treatment of malignant pleural Jan van Meerbeeck Department of Respiratory Medicine and Thoracic Oncology, Ghent University Hospital, Belgium Trends in incidence ES18 Chair: Jim tewaternaude Asbestos Relief Trust, South Africa and School of Public Health, University of Cape Town, South Africa Trends in incidence Ken Takahashi Department of Environmental Epidemiology, University of Occupational and Environmental Health, Japan 24
5 Room B1 Time: 13:00-13:40 Pathology Lecture-1 Advances in the pathology of malignant Chair: Yoshihiro Matsuno Hokkaido University Hospital, Japan ES PL01 Advances in the pathology of malignant Time: 13:40-14:20 Andrew Churg Department of Pathology, University of British Columbia, Canada Pathology Lecture-2 Cytological diagnosis for Chair: Françoise Galateau-Sallé University of Caen, France ES PL02 Cytological diagnosis for Time: 15:00-15:40 Toshiaki Kamei Division of Pathology, Yamaguchi Grand Medical Center, Japan Pathology Lecture-3 Verification of the consensus statement from the IMIG2006 Chair: Yuichi Ishikawa The Cancer Institute, Japanese Foundation for Cancer Research, Japan ES PL03 Verification of the consensus statement from IMIG 2006 Time: 15:40-16:20 Victor Roggli Department of Pathology, Duke University Medical Center, USA Pathology Lecture-4 Mesothelioma with special references to diagnostic accuracy Chair: Steven Mutsaers University of Western Australia, Australia ES PL04 Mesothelioma with special references to diagnostic accuracy Kouki Inai Division of Medical Intelligence and Informatics, Hiroshima University Graduate School of Biomedical Sciences, Japan 25
Educational Session. Chair: Shotaro Maeda Tama-Nagayama Hospital, Nippon Medical School, Japan. Mechanisms of asbestos-induced carcinogenesis
Tuesday, Aug. 31 Room A Time: 8:00-8:10 Opening Remarks Time: 8:10-8:35 The mesothelial cell ES01 Time: 8:35-9:00 Educational Session Chair: Shotaro Maeda Tama-Nagayama Hospital, Nippon Medical School,
More information1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
More informationGRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native
More informationInternational Symposium on Malignant Pleural Mesothelioma
International Symposium on Malignant Pleural Mesothelioma LONDON 2015 Friday 6th & Saturday 7th November 2015 Jumeirah Carlton Tower Hotel Cadogan Place Knightsbridge London SW1X 9PY United Kingdom Dear
More informationMalignant Mesothelioma State of the Art
Malignant Mesothelioma State of the Art Paul Baas The Netherlands Cancer Institute August 12, 2011, Carlsbad, CA Summary Diagnosis; epithelial type subdivided Pleiomorphic vs other Staging: IASLC-IMIG
More informationSurvey of Mesothelioma Associated with Asbestos Exposure in Japan
The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics
More informationSurgical therapy of. who should be operated
SAMO Interdisciplinary Workshop on Chest Tumors Lucerne, 13th and 14th January 2012 Surgical therapy of mesothelioma, who should be operated Walter Weder MD Professor of Surgery University Hospital Zurich
More informationMesothelioma 2014. Paul Baas Department of Thoracic Oncology The Netherlands Cancer Institute Amsterdam
Mesothelioma 2014 Paul Baas Department of Thoracic Oncology The Netherlands Cancer Institute Amsterdam Disclosures Grants from Pfizer and Roche Advisor for MSD and Verastem Once upon a time. http://amlbenzene.net/diseases-asbestos.htm
More informationL Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,
More informationMalignant pleural mesothelioma P/D vs. EPP
3 rd International Thoracic Oncology Congress Dresden, September 13 15, 2012 Malignant pleural mesothelioma P/D vs. EPP Walter Weder, MD Professor of Surgery Dokumentenname Datum Seite 1 Extrapleural Pneumonectomy
More informationTHE NEWEST TRENDS IN LUNG CANCER & MESOTHELIOMA CASES
Conference Chairs: THE NEWEST TRENDS IN LUNG CANCER & MESOTHELIOMA CASES LEADING DOCTORS, SCIENTISTS & LAWYERS DISCUSS THE EPIDEMIOLOGY, BIOLOGY & PRACTICAL ISSUES THAT AFFECT CASE FILINGS, TRIALS, SETTLEMENTS,
More informationInternational Journal of Case Reports in Medicine
International Journal of Case Reports in Medicine Vol. 2013 (2013), Article ID 409830, 15 minipages. DOI:10.5171/2013.409830 www.ibimapublishing.com Copyright 2013 Andrew Thomas Low, Iain Smith and Simon
More informationThe New International Staging System Lung Cancer
The New International Staging System Lung Cancer Valerie W. Rusch, MD Chief, Thoracic Surgery Memorial Sloan-Kettering Cancer Center Chair, Lung and Esophagus Task Force, American Joint Commission on Cancer
More informationTargeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
More informationSciRevision Japanese Clients/pro bono: Universities, Institutes, Companies (updated 1 November, 2007)
SciRevision Japanese Clients/pro bono: Universities, Institutes, Companies (updated 1 November, 2007) Agricultural Technology Institute of Nagano Farmers Federation Agriculture, Forestry and Fisheries
More informationMay 18, 2013 Sheraton Delfina Santa Monica, California
3rd International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma May 18, 2013 Sheraton Delfina Santa Monica, California Malignant pleural mesothelioma (MPM) is an unusual cancer
More informationWe look forward to both your participation and contribution to this meeting.
Dear Colleagues, It is a great pleasure to invite you to participate in the joint symposium MALIGNANT PLEURAL MESOTHELIOMA: A CHANGING PARADIGM OF CARE organized by Division of Thoracic Surgery, Brigham
More informationA Conference on Asbestos & Mesothelioma
A Conference on Asbestos & Mesothelioma May 3 rd 4 th, 2010 Las Vegas, NV Encore, a Wynn Hotel Faculty Jerrold Abraham Wayne Berman David Bernstein Arnold Brody Andrew Churg David Egilman Murray Finklestein
More informationPleural Mesothelioma 2013:
The Penn Mesothelioma and Pleural Program and Penn Presbyterian Medical Center Present Pleural Mesothelioma 2013: Multidisciplinary Diagnosis, Treatment and Investigation A C M E / C E - C E R T I F I
More informationMay 18, 2013 Sheraton Delfina Santa Monica, California
3rd International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma May 18, 2013 Sheraton Delfina Santa Monica, California Malignant pleural mesothelioma (MPM) is an unusual cancer
More informationMesothelioma. 1. Introduction. 1.1 General Information and Aetiology
Mesothelioma 1. Introduction 1.1 General Information and Aetiology Mesotheliomas are tumours that arise from the mesothelial cells of the pleura, peritoneum, pericardium or tunica vaginalis [1]. Most are
More informationCourtney Broaddus University of California, San Francisco General Hospital, USA
Wednesday, Sept. 1 Room A Time: 8:30-8:35 Welcome Address: Time: 8:30-8:40 Takashi Nakano, Conference Chair IMIG 2010 Hyogo College of Medicine, Japan President s address: Time: 8:40-9:00 Hedy Kindler
More informationAdvances in Lung Cancer: A Multidisciplinary Approach
Advances in Lung Cancer: A Multidisciplinary Approach Saturday, April 25, 2015 127 Public Square Cleveland, Ohio Learning Objectives About the Course This one-day course will provide a topical, clinically
More informationOccupational respiratory diseases due to Asbestos. Dirk Dahmann, IGF, Bochum
Occupational respiratory diseases due to Asbestos Dirk Dahmann, IGF, Bochum Contents Introduction Diseases Further Effects Preventive Strategies Conclusion Asbestos minerals Woitowitz, 2003 Imports (+
More informationMalignant Mesothelioma: an Update
Malignant Mesothelioma: an Update Nico van Zandwijk Asbestos Diseases Research Institute Bernie Banton Centre University of Sydney Australia Physicians Week RACP 19-5-2009 Health Risks of Asbestos Fibers
More informationReport on New Patented Drugs - Alimta
Report on New Patented Drugs - Alimta Under its transparency initiative, the PMPRB publishes the results of the reviews of new patented drugs by Board Staff, for purposes of applying the PMPRB s Excessive
More informationThe Features of World-Class Universities
The Features of World-Class ersities Hsiou-Hsia Tai Professor, Institute of Education Associate Dean, College of Humanities and Social Sciences National Chiao Tung ersity Hsin-chu, Taiwan Introduction
More informationMay 21, 2011 Sheraton Delfina Santa Monica, California
1st International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma May 21, 2011 Sheraton Delfina Santa Monica, California Malignant pleural mesothelioma (MPM) is an unusual cancer
More informationMesothelioma Applied Research Foundation www.curemeso.org
Mesothelioma Applied Research Foundation www.curemeso.org Board of Directors Michael Becich PhD Gen. Steven Blum Lee Krug MD David Ettinger MD Axel Ranier Richard Mosca Erica Iacono Terry Lynch Hanne Minz
More informationTHE NEWEST TRENDS IN LUNG CANCER & MESOTHELIOMA CASES
Conference Chairs: THE NEWEST TRENDS IN LUNG CANCER & MESOTHELIOMA CASES LEADING DOCTORS, SCIENTISTS & LAWYERS DISCUSS THE EPIDEMIOLOGY, BIOLOGY & PRACTICAL ISSUES THAT AFFECT CASE FILINGS, TRIALS, SETTLEMENTS,
More informationMESOTHELIOMA. Not Just a Late Night Commercial. Graciela Hoal, RN, MSN, ACNP-BC
MESOTHELIOMA Not Just a Late Night Commercial Graciela Hoal, RN, MSN, ACNP-BC Saturday Session Thoracic Surgery Nurse Practitioner Greater Los Angeles Veteran Affairs Objectives Course Objectives: Discuss
More informationMesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology
MesoPDT Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI Image Assisted Laser Therapy for Oncology Unité Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI "Image
More informationREPORT PERSPECTIVES IN LUNG CANCER 2010 AMSTERDAM
REPORT PERSPECTIVES IN LUNG CANCER 2010 AMSTERDAM Valerie Van Damme, Isabelle Wauters, Johan Vansteenkiste Univ. Hospital Leuven and Leuven Lung Cancer Group Introduction Perspectives in Lung Cancer (PILC)
More informationPost-operative intrapleural chemotherapy for mesothelioma
Post-operative intrapleural chemotherapy for mesothelioma Robert Kratzke, MD John Skoglund Chair for Lung Cancer Research Section of Heme-Onc-Transplant University of Minnesota Medical School Efficacy
More informationA standardized technique of radical pleurectomy for mesothelioma that achieves a macroscopic complete resection, regardless of tumor bulk
Thursday, Sept. 2 Room A Time: 9:00-10:30 Round-table Discussion: Surgery-I RD02-1 Chair: Valerie Rusch Thoracic Surgery Service, Department of Surgery Memorial Sloan-Kettering Cancer Center Harvey Pass
More informationClinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines
Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines Wieneke Buikhuisen The Netherlands Cancer Institute Amsterdam The Netherlands Case (1) Male, 56 year
More informationGIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE Personal Information Date of birth July 2, 1953 Place of birth Torino, Italy Office address Department of Oncology S. Luigi Gonzaga Hospital, Oncology
More informationU.S. News Best Global Universities Rankings: An inside look at the latest results and methodology
U.S. News Best Global Universities Rankings: An inside look at the latest results and methodology Robert J. Morse, Chief Data Strategist U.S. News & World Report 6th International Conference on World-Class
More informationIntroduction to the. Mesothelioma Applied Research Foundation
Introduction to the Mesothelioma Applied Research Foundation Who We Are Mission Statement The Meso Foundation is the only national non-profit dedicated to eradicating mesothelioma as a life-ending disease.
More informationMalignant pleural mesothelioma (MPM) is an uncommon
ORIGINAL ARTICLE Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database Valerie W. Rusch, MD,* Dorothy Giroux, Catherine Kennedy, Enrico Ruffini, Ayten K.
More informationLung Cancer & Mesothelioma 2011-2015
Lung Cancer & Mesothelioma 2011-2015 Annex G Mesothelioma 1. The vision for mesothelioma services is set out in the Mesothelioma Framework issued by DH on 26 February 2007 (supported by the British Thoracic
More informationIndependent Validation of the Prognostic Gene Expression Ratio Test in Formalin Fixed, Paraffin Embedded (FFPE) Mesothelioma Tumor Tissue Specimens
Independent Validation of the Prognostic Gene Expression Ratio Test in Formalin Fixed, Paraffin Embedded (FFPE) Mesothelioma Tumor Tissue Specimens Assunta De Rienzo, Ph.D. 1, Robert W. Cook, Ph.D. 2,
More informationAdvances in Treatment of Malignant Pleural Mesothelioma: A Reason for Hope
Advances in Treatment of Malignant Pleural Mesothelioma: A Reason for Hope Daniel H. Sterman, M.D. Associate Professor of Medicine and Surgery Co-Director, PENN Mesothelioma and Pleural Program University
More informationMaster Online Study Program @dvanced Oncology. Study part time team up internationally!
Master Online Study Program @dvanced Oncology Study part time team up internationally! Ulm University is developing an innovative international postgraduate study program @dvanced Oncology addressing clinical
More informationReport on the Committee on Assessment of the Health Effects of Fine Particulate Matter on Public Health
Report on the Committee on Assessment of the Health Effects of Fine Particulate Matter on Public Health Friday, April 4, 2008 Policy and Coordination Division, Environmental Management Bureau of The Ministry
More informationبسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma
More informationUpdate on Clinical Trials and Foundation Funded Grants
Update on Clinical Trials and Foundation Funded Grants Mary Hesdorffer, MS, APRN-BC Medical Liaison Meso Foundation www.curemeso.org Delivering the Diagnosis Delivering the Diagnosis Day 1 Taking control
More informationA Career in Pediatric Hematology-Oncology? Think About It...
A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T
More informationELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
More informationFACULTY OF ALLIED HEALTH SCIENCES
FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes
More informationMesothelioma. Malignant Pleural Mesothelioma
Mesothelioma William G. Richards, PhD Brigham and Women s Hospital Malignant Pleural Mesothelioma 2,000-3,000 cases per year (USA) Increasing incidence Asbestos (50-80%, decreasing) 30-40 year latency
More informationSummary Report of Basic Survey on Wage Structure (starting salary)
Summary Report of Basic Survey on Wage Structure (starting ) 2011 Contents Outline of Survey Page 1 Definitions Page 3 Summary of Results 1. Starting by school career Page 4 2. Starting by enterprise size
More informationUNIVERSITY TOP 50 BY SUBJECTS a) Arts and Humanities Universities 2011-2012
Times Higher Education s World University Rankings UNIVERSITY TOP 50 BY SUBJECTS a) Arts and Humanities Universities 2011-2012 Top 50 Arts and Humanities Universities 2011-2012 1 Stanford University United
More informationGlobalization of Higher Education in Japan
Globalization of Higher Education in Japan: ( Made by Office for International Planning Higher Education Bureau ) 10 th of March, 2014 Hideshi SEMBA, Mission of Japan to the EU Globalization of Higher
More informationMulti-disciplinary Thoracic Oncology:
Multi-disciplinary Thoracic Oncology: State-of-the-art and new directions Friday, June 13, 2014 7:15am 4:45pm PROGRAM CO-DIRECTORS Balazs Halmos, MD Jeffrey L. Port, MD Ronald J. Scheff, MD Joshua R. Sonett,
More informationLuis D. Carcorze Soto, MD PGY-3
Luis D. Carcorze Soto, MD PGY-3 Peritoneal Surface Malignancies Peritoneum Patient Selection Operative Technique HIPEC EPIC Primary: Primary Peritoneal Carcinoma Malignant Peritoneal Mesothelioma Metastatic:
More informationAppendix 1 Current list of approved qualifications for Locum Tenens registration
Appendix 1 Current list of approved qualifications for Locum Tenens registration Anaesthesia Fellowship of the Australian and New Zealand College of Anaesthetists Fellowship of the Faculty of Anaesthetists,
More informationHow To Prevent Asbestos Related Diseases
BD5.3 Report of Working Groups Elimination of Asbestos-related Diseases ICOH 2012 March 18, 2012 Cancun Report of WG Elimination of Asbestos-related Diseases Dr. Sherson mail to ICOH President of 7 December
More informationPrincipal Investigator: Valerie W. Rusch, MD, FACS, Chief, Thoracic Surgery Memorial Sloan-Kettering Cancer Center
Protocol 1101-1088 Phase I study of intra-pleural administration of GL-ONC1 in patients with malignant pleural effusion: primary, metastases and mesothelioma Principal Investigator: Valerie W. Rusch, MD,
More informationExchange studies in Dentistry
Exchange studies in Dentistry 2013-2014 Exchange studies in Dentistry Full programme information 300 Higher Education Credits, 5 years. The dentist is the leader of the dental care team and is responsible
More informationExtrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012
Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos
More informationEpidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD
Epidemiology, Staging and Treatment of Lung Cancer Mark A. Socinski, MD Associate Professor of Medicine Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of
More informationUpdate on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
More informationScientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)
Under the Auspices of Organized by 10th International Symposium Advanced Ovarian Cancer: Optimal Therapy. Update Valencia, Spain, 6th March 2015 Directors Andrés Poveda Fundación Instituto Valenciano de
More informationThere must be an appropriate administrative structure for each residency program.
Specific Standards of Accreditation for Residency Programs in Radiation Oncology 2015 VERSION 3.0 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation
More informationDalhousie University 2014/2015 Enrolment Statistics - Enrolment by Faculty 1 and Field of Study as of December 1 (Headcounts) December 1, 2014
Dalhousie Agriculture Agricultural Business 45 4 49 49 40 9 49 49 Agricultural Economics 13 3 16 16 7 4 11 11 Agriculture 1 3 4 22 23 45 53 11 64 113 33 13 46 55 10 65 111 Animal Science 139 5 144 144
More informationBY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA
BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA 1 CUTTING-EDGE ISSUES IN ASBESTOS LITIGATION CONFERENCE Scott Masterson Lewis, Brisbois, Bisgaard & Smith, LLP 1180 Peachtree Street, NE, Suite 2900
More informationResults of Accreditations Performed by the Japan University Accreditation Association
Results of Accreditations Performed by the Japan University Accreditation Association July 18, 2014 Introduction In 2002, the Certified Evaluation and Accreditation System was introduced in Japan (enforced
More informationNational Framework for Excellence in
National Framework for Excellence in Lung Cancer Screening and Continuum of Care declaration of purpose Rights and Expectations THE RIGHTS OF THE PEOPLE Lung cancer kills more Americans than the next four
More informationPlaintiffs Experts Latest Pathological Theories
Plaintiffs Experts Latest Pathological Theories Kurt B. Gerstner Campbell Campbell Edwards & Conroy, P.C. One Constitution Center Boston, MA 02129 (617) 241-3086 kgerstner@campbell-trial-lawyers.com Kurt
More informationProbe: Could you tell me about when?
PERIODIC ASSESSMENT OF TREATMENT AND VITAL/DISEASE STATUS Periodic Assessment of Cancer Treatment and Disease Status (To be administered to patient at 3 months and reviewed at 6, 9 and 12 months) Instructions:
More informationLessons learned from the Western Australian experience with mesothelioma
Lessons learned from the Western Australian experience with mesothelioma Alison Reid, Western Australian Institute for Medical Research In partnership with Nick de Klerk, Nola Olsen, Jan Sleith, Geoffrey
More informationJ of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063
PERITONEAL MALIGNANT MESOTHELIOMA: A RARE S. R. Dhamotharan 1, S. Shanthi Nirmala 2, F. Celine Foustina Mary 3, M. Arul Raj Kumar 4, R. Vinothprabhu 5 HOW TO CITE THIS ARTICLE: S. R. Dhamotharan, S. Shanthi
More informationElenco dei periodici elettronici in Ovid Full text
Academic Medicine Addictive Disorders & Their Treatment Advances in Anatomic Pathology Age & Ageing AIDS AIDS Patient Care & Stds AJN, American Journal of Nursing Alzheimer Disease & Associated Disorders
More informationTargeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
More informationGOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA. 17-18 June 2010 Golnik, Slovenia. Chair: T. Cufer, SI - G.L. Ceresoli, IT
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA 17-18 June 2010 Golnik, Slovenia Chair: T. Cufer, SI - G.L. Ceresoli, IT AIM OF THE COURSE The incidence
More informationBritish Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015
0116 250 2811 dawn.mckinley@uhl-tr.nhs.uk www.btog.org @BTOGORG British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015 BTOG s Aim BTOG is the multi-disciplinary group for professionals
More informationIndividualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing
Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing These Are Hopeful Times for Lung Cancer Survivors When people first learn they have cancer, they are often afraid. But
More informationHealth effects of occupational exposure to asbestos dust
Health effects of occupational exposure to asbestos dust Authors: N.Szeszenia-Dąbrowska, U.Wilczyńska The major health effects of workers' exposure to asbestos dust include asbestosis, lung cancer and
More information- Compensation issues
Charité- Universitätsmedizin Berlin Institut für Arbeitsmedizin Prof. Dr. med. X. Baur Prevention, recognition and compensation of asbestosinduced diseases (AD) - Which diseases are asbestos-related? -
More informationAsbestos-Related Cancer Research and Prevention
Asbestos-Related Cancer Research and Prevention Professor Nico van Zandwijk Asbestos Diseases Research Institute University of Sydney International Conference on Asbestos Awareness and Management 18 November
More informationHow To Prepare A Meeting For A Health Care Conference
THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY EXECUTIVE SUMMARY 1. All patients in Lothian with thoracic malignancies should be discussed at designated times in pathway (see App
More informationCancer and the immune system: can we beat cancer at its own game?
Cancer and the immune system: can we beat cancer at its own game? Andrew R. Haas, MD, PhD Assistant Professor of Medicine University of Pennsylvania Medical Center Philadelphia, Pa Why can t immune
More informationLung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care
Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care Saturday, April 27, 2013 Cleveland Marriott Downtown at Key Center 127 Public Square Cleveland, Ohio Learning
More informationMESOTELIOMA and CHRYSOTILE
MESOTELIOMA and CHRYSOTILE in RUSSIA Kashansky S.V., Grinberg L.M., Kuzmin S.V., Berdnikov R.B., Berzin S.A. Ekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers
More informationInfluence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis
Influence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis Andrew Churg, MD Department of Pathology University of British Columbia Vancouver, BC, Canada Techniques,
More informationHow To Treat Mesothelioma
Mesothelioma in the UK Liz Darlison Mesothelioma UK The National Macmillan Mesothelioma Resource Centre June 2010 Mesothelioma Applied Research Foundation - 2010 www.curemeso.org Contents Size of Mesothelioma
More informationBrigham and Women s Hospital, Boston, MA, USA; 2 Verastem, Inc., Boston, MA, USA
Determination of Biomarker Response in a Phase II Window of Opportunity Study of Defactinib (VS 6063), a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with Resectable Malignant Pleural Mesothelioma
More informationExploring the Role of Vitamins in Achieving a Healthy Heart
Exploring the Role of Vitamins in Achieving a Healthy Heart There are many avenues you can take to keep your heart healthy. The first step you should take is to have a medical professional evaluate the
More informationJapanese Government s strategy on international education
Japanese Government s strategy on international education Prime Minister Abe s focus on global human capital Prime Minister Abe has developed the Growth Strategy in his second term as leader of Japan,
More informationFuture Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
More informationDo we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database
Featured Article Do we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database Valerie W. Rusch 1, Dorothy Giroux 2 1 Memorial Sloan-Kettering Cancer Center, New
More information2016 Admissions Guide: Doctoral Program of Medicine. Graduate School of Medicine, the University of Tokyo
This English version is a courtesy translation. Only the Japanese version is final. 2016 Admissions Guide: Doctoral Program of Medicine Graduate School of Medicine, the University of Tokyo 平 成 2 8 年 度
More informationPage 1/.. USA / Canada - South Africa Schedule No. 4 / 2011-Jan-24
USA / Canada South Africa Schedule No. 4 / 2011Jan24 Page 1/.. USA / Canada South Africa Schedule No. 4 / 2011Jan24 Page 2/.. USA / Canada South Africa Schedule No. 4 / 2011Jan24 Page 3/.. USA / Canada
More information2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Wednesday Oct 7th, 2015 Congress Center (Hörsaal 1 3) Marien Hospital Herne Accreditation by the Medical Chamber
More informationCancerStemCell Markers in Lung Cancers: Proofsof. Reservations. Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany
CancerStemCell Markers in Lung Cancers: Proofsof ConceptsandSome Reservations Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany Lung cancer: highest death rate and poorest patient survival
More informationMalignant Pleural Mesothelioma in Singapore
RESEARCH COMMUNICATION C SP Yip 1, HN Koong 2, CM Loo 3, KW Fong 1* Abstract Aim: To examine the clinical characteristics and outcomes of malignant pleural mesothelioma (MPM) in Singapore. Methods and
More informationLife Insurance Fact Book (2014)
Life Insurance Fact Book (214) The Life Insurance Association of Japan Introduction The Life Insurance Fact Book summarizes key performance indicators of life insurance companies operating in Japan. We
More informationAnnouncement of Changes in Executive Personnel and Changes in Responsibilities of Executive Personnel (as of April 1, 2014)
March 4, 2014 Meiji Yasuda Life Insurance Company Announcement of Changes in Executive Personnel and Changes in Responsibilities of Executive Personnel (as of April 1, 2014) Meiji Yasuda Life Insurance
More information